# Filing Detail

Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001104659-25-024021
Filing Date
2025-03-14
Accepted
2025-03-14 17:16:00
Documents
35

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-4/A | tm253007-7_s4a.htm | S-4/A | 8584738
2 | EXHIBIT 5.1 | tm253007d9_ex5-1.htm | EX-5.1 | 14605
3 | EXHIBIT 8.1 | tm253007d9_ex8-1.htm | EX-8.1 | 13830
4 | EXHIBIT 8.2 | tm253007d9_ex8-2.htm | EX-8.2 | 13539
5 | EXHIBIT 10.6 | tm253007d9_ex10-6.htm | EX-10.6 | 59641
6 | EXHIBIT 23.1 | tm253007d9_ex23-1.htm | EX-23.1 | 2048
7 | EXHIBIT 23.2 | tm253007d9_ex23-2.htm | EX-23.2 | 2450
8 | EXHIBIT 23.3 | tm253007d9_ex23-3.htm | EX-23.3 | 6750
9 | EX-FILING FEES | tm253007d9_ex-filingfees.htm | EX-FILING FEES | 25979
10 | GRAPHIC | bc_clinical-4clr.jpg | GRAPHIC | 12265
11 | GRAPHIC | bc_sibeprenlimab-4clr.jpg | GRAPHIC | 24782
12 | GRAPHIC | fc_baff-4clr.jpg | GRAPHIC | 69902
13 | GRAPHIC | fc_jademabs-4clr.jpg | GRAPHIC | 111834
14 | GRAPHIC | fc_novel-4clr.jpg | GRAPHIC | 89343
15 | GRAPHIC | fc_plasma-4clr.jpg | GRAPHIC | 61470
16 | GRAPHIC | ft_lucid-bw.jpg | GRAPHIC | 6470
17 | GRAPHIC | lc_human-4clr.jpg | GRAPHIC | 19409
18 | GRAPHIC | lc_igan-4clr.jpg | GRAPHIC | 36939
19 | GRAPHIC | lc_reduction-4clr.jpg | GRAPHIC | 93220
20 | GRAPHIC | lc_sibeprenlimab-4clr.jpg | GRAPHIC | 63472
21 | GRAPHIC | lc_treatment-4clr.jpg | GRAPHIC | 63875
22 | GRAPHIC | lc_upcr-4clr.jpg | GRAPHIC | 96147
23 | GRAPHIC | lg_aerovate-4clr.jpg | GRAPHIC | 14066
24 | GRAPHIC | lg_jade-4clr.jpg | GRAPHIC | 13465
25 | GRAPHIC | lg_lucid-4c.jpg | GRAPHIC | 9285
26 | GRAPHIC | px_aerovatecommon25pg01-4c.jpg | GRAPHIC | 556111
27 | GRAPHIC | px_aerovatecommon25pg02-4c.jpg | GRAPHIC | 344833
28 | GRAPHIC | sg_lucidcapital-bw.jpg | GRAPHIC | 6325
29 | GRAPHIC | tb_acei-4clr.jpg | GRAPHIC | 122389
30 | GRAPHIC | tb_belimumab-4clr.jpg | GRAPHIC | 77170
31 | GRAPHIC | tb_taci-4clr.jpg | GRAPHIC | 151691
32 | GRAPHIC | tm253007d9_ex8-1img001.jpg | GRAPHIC | 3447
33 | GRAPHIC | tm253007d9_ex8-1img002.jpg | GRAPHIC | 3447
34 | GRAPHIC | tm253007d9_ex5-1img001.jpg | GRAPHIC | 6696
35 | GRAPHIC | tm253007d9_ex5-1img01.jpg | GRAPHIC | 2614
| Complete submission text file | 0001104659-25-024021.txt |  | 11528322

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-283562 | Film No.: 25741296
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)